VistaGen Wins NIH Funding

South San Francisco-based VistaGen Therapeutics, Inc., a biopharmaceutical firm specializing in the use of embryonic stem cell technologies in drug development, was awarded a $1.2 million grant from National Institutes of Health, the company announced Tuesday.

The funding is the final phrase of a $4.3 grant for the development of AV-101, a potential treatment for neuropathic pain, Parkinson’s disease and epilepsy.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

New tenant protections legislation being introduced

Advocates say many landlords skirt buyout laws by failing to report or using aggressive tactics

City could try to stop Lyft from dropping cash payments for bikeshare

A city supervisor hopes to force Lyft to keep accepting cash for… Continue reading

SF judge holds GOP House candidate Omar Navarro on stalking charges

Navarro is accused of his threatening ex-girlfriend: ‘I’m going to have antifa come after your family’

San Francisco community advocate to join District 5 supervisor’s race

Daniel Landry is the former president of the New Community Leadership Foundation

Most Read